glp-1 study news A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Glucagon-like peptide-1 receptor: mechanisms and

To investigate whether the rescue effect by the drugs is associated with AMPK pathway, we examined the expression levels of AMPK and downstream mTOR pathway markers using RT-qPCR in the LMNA mutant transgenic fish with or without treatment

Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs

These findings offer valuable targets for the development of novel treatment approaches

Patients who are not approved may be advised to pursue GLP-1 treatment through a different access pathway that better accommodates their clinical situation

Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma